Side-by-side comparison of AI visibility scores, market position, and capabilities
Teaneck NJ IT services (NASDAQ: CTSH) $19.7B FY2024 revenue; Belcan engineering $1.3B acquisition, GenAI 100+ engagements, NextGen transformation competing with Infosys, Wipro, and Accenture.
Cognizant Technology Solutions Corporation is a Teaneck, New Jersey-based information technology services and consulting company — publicly traded on the NASDAQ (NASDAQ: CTSH) as an S&P 500 Information Technology component — providing IT services, digital transformation consulting, cloud migration, enterprise application management, and business process outsourcing through approximately 340,000 employees primarily in India (Chennai, Hyderabad, Pune delivery centers) serving clients in financial services, healthcare, manufacturing, and communications sectors in North America, Europe, and the rest of world. In fiscal year 2024, Cognizant reported revenues of $19.7 billion with modest growth as the IT services sector emerged from the 2023 discretionary spending slowdown, with the company's NextGen strategy (investing in generative AI services, cloud-native application transformation, and digital operations) driving bookings growth. CEO Ravi Kumar S. — joined January 2023 from Infosys — has executed a talent and client engagement restructuring focused on "moving up the value chain" from labor-arbitrage IT outsourcing toward higher-value consulting and AI-integration services: the Belcan acquisition ($1.3 billion, 2023) added 5,500 engineering services professionals serving US aerospace and defense customers (Boeing, Lockheed Martin, General Dynamics), expanding Cognizant beyond IT services into engineering R&D outsourcing. Cognizant's generative AI practice (partnering with Google Cloud, Microsoft Azure, AWS for GenAI implementation) grew to 100+ active GenAI client engagements by 2024 as enterprise clients deployed AI copilots, process automation, and customer service chatbots on Cognizant-managed cloud infrastructure.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.